Table 2.
The other characteristics of study patients
| All (n = 39) | CPC 1, 2 (n = 8) | CPC 3, 4, 5 (n = 31) | p value | |
|---|---|---|---|---|
| Body mass index (kg/m2) | 26.6 ± 4.5 | 26.0 ± 4.0 | 26.8 ± 4.7 | 0.69 |
| Left ventricular ejection fraction (%) | 17.9 ± 12.4 | 19.2 ± 7.4 | 17.6 ± 13.3 | 0.79 |
| Diabetes mellitus (n, %) | 7 (17.9) | 3 (37.5) | 4 (12.9) | 0.29 |
| Dyslipidemia (n, %) | 31 (79.5) | 8 (100) | 23 (74.2) | 1.0 |
| Hypertension (n, %) | 12 (30.8) | 3 (37.5) | 9 (29.0) | 0.24 |
| Smoking (current smoker) (n, %) | 11 (28.2) | 5 (62.5) | 6 (19.4) | 0.38 |
| Laboratory data | ||||
| Total cholesterol (mg/dL) | 150.9 ± 58.1 | 111.8 ± 51.2 | 161.2 ± 56.5 | 0.09 |
| Triglycerides (mg/dL) | 112.8 ± 71.1 | 110.9 ± 57.5 | 113.4 ± 75.8 | 0.46 |
| HDL-C (mg/dL) | 33.5 ± 12.2 | 31.0 ± 10.3 | 34.2 ± 12.8 | 0.48 |
| LDL-C (mg/dL) | 92.7 ± 38.2 | 71.9 ± 33.9 | 99.2 ± 37.8 | 0.08 |
| eGFR (ml/min) | 46.6 ± 17.1 | 51.1 ± 22.7 | 45.5 ± 15.5 | 0.52 |
| Creatine kinase (IU/L) | 420 ± 1158 | 234 ± 291 | 468 ± 1291 | 0.36 |
| Albumin (g/dL) | 3.35 ± 0.54 | 3.08 ± 0.75 | 3.43 ± 0.46 | 0.24 |
| Potassium concentration (mM/L) | 4.5 ± 0.8 | 4.2 ± 0.7 | 4.6 ± 0.8 | 0.28 |
| D-dimar (μg/ml) | 27.7 ± 48.9 | 19.8 ± 29.8 | 29.8 ± 53.2 | 0.56 |
| Soluble fibrin (μg/ml) | 33.8 ± 34.5 | 21.7 ± 22.4 | 36.8 ± 37.2 | 0.35 |
| Brain natriuretic peptide (pg/mL) | 292 ± 683 | 675 ± 1407 | 187 ± 228 | 0.36 |
| Blood gas analysis | ||||
| Potential of hydrogen | 6.94 ± 0.16 | 6.99 ± 0.18 | 6.93 ± 0.15 | 0.38 |
| Lactate (mg/dL) | 102.9 ± 32.8 | 107.1 ± 40.2 | 101.9 ± 31.2 | 0.74 |
| Bicarbonate (mmol/L) | 16.3 ± 4.5 | 13.4 ± 4.1 | 17.1 ± 4.1 | 0.04 |
| PCO2 (mmHg) | 79.3 ± 28.6 | 58.3 ± 26.4 | 84.7 ± 27.0 | 0.03 |